Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07913048
PHASE1

A Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants

Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

To evaluate the pharmacokinetic characteristics of a single intravenous injection of KL0011034 injection in healthy non-elderly and elderly trial participants. To evaluate the pharmacodynamics and safety of a single intravenous injection of KL0011034 injection in healthy non-elderly and elderly trial participants.

Official title: A Single-Dose Study to Evaluate the Pharmacokinetics/Pharmacodynamics and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-11-20

Completion Date

2026-11-30

Last Updated

2026-11-03

Healthy Volunteers

Yes

Interventions

DRUG

KL0011034 injection

Intravenous injection, single dose

Locations (1)

The Third XIANGYA Hospital of Central South University

Changsha, Hunan, China